Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. - Wikidata - wikimedia - TriplyDB

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.

http://www.wikidata.org/entity/Q34747331

about

Purine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemia Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines Ofatumumab plus chlorambucil as a first-line therapy in less fit patients with chronic lymphocytic leukemia: analysis of COMPLEMENT1 and other monoclonal antibodies association data BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia Clinical implications of the molecular genetics of chronic lymphocytic leukemia How will B-cell-receptor-targeted therapies change future CLL therapy?Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.An update on the management of chronic lymphocytic leukaemia.Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia.Chronic lymphocytic leukemia in India--a clinico-hematological profile.Alemtuzumab for B-cell chronic lymphocytic leukemia.Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia.A case of CLL that was successfully treated resulted in the immediate development of AML from a coexistent myeloid line that had been suppressed.Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.Management of chronic lymphocytic leukemia.Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.Anti-CD37 antibodies for chronic lymphocytic leukemia.Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells.Role of rituximab in first-line treatment of chronic lymphocytic leukemia.The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.The development of marked elevation in white blood cell count does not predict inferior outcome in chronic lymphocytic leukemia.B-chronic lymphocytic leukemia: practical aspects.Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil and glucocorticoids.Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia.Choosing first-line therapy for chronic lymphocytic leukemia.Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom's Macroglobulinemia Monocyte-derived dendritic cells in chronic lymphocytic leukemia.

P2860

Q24198941-3449B787-14CE-4C69-B08E-D5F791E7E776 Q24616084-1D200456-941D-4291-9B1C-F0471019381B Q26738934-2E3DB5FC-8620-441A-B5D2-1E91721BA4AD Q26765624-36CAAF0E-C77C-4B81-B50D-B256E63C5B59 Q26830955-94650F5C-66C4-451A-89BF-2205228E5D82 Q27024187-8A241829-110E-4AB1-8B60-D24C55F62974 Q27851685-BF3C430B-D633-4B78-862C-41CE34060F58 Q28082086-2FE27664-2F5F-4CD5-8DAC-02F80359E968 Q28082120-096A852A-8B6B-4A2B-B59F-C3C59D6B1F81 Q28146150-78615787-10A7-4E38-87B1-85C70715F690 Q30243968-D2556FBA-628F-4ADC-9A7E-4BE311D2BDC5 Q30341946-9A5C917A-5D9F-4494-BE46-9FFE22388F27 Q33186850-E60D9C5C-6948-4B80-88C4-CD53DFD889A8 Q33329000-F99BC5FC-238B-486C-A30E-89B4B1801C4A Q33375516-0D385F9B-895F-48F4-9FED-9945D491494A Q33380135-E69D2577-8CDC-4D08-A163-9A1E46801BC8 Q33394947-75347ACE-C802-440C-A663-594DC50DCD38 Q33421691-EDD64200-E10B-42CC-A97F-23E4099B0289 Q33437042-A4E4B634-1849-46BC-A146-A4F7EEB40134 Q33517828-EE1D5FE3-4670-4966-9EA4-C089CAFD7653 Q33695912-A3513C7E-2C08-4FD4-94A4-D823BF3A2806 Q33856215-F4FA2909-7713-4694-AE3C-5A3F9F187EB9 Q33880538-69EE48B5-B963-4C4A-900B-8729C3E31182 Q33886052-3AD147C8-284D-46F4-9751-3BE3A6B392DF Q33956034-72FBA2BD-D283-4223-BEEE-DEE8E7B5059B Q34016413-647655BC-2426-4875-B1F1-C1C4CB5C51D3 Q34293457-6906056B-0D6A-495F-9DFA-2DD8A6FC9A79 Q34405641-38B18C6C-481B-4D16-9EBD-DE2D09F40CF5 Q34507114-220DAEB0-BB3C-47F7-852A-99FA566E137A Q34574147-58289D43-2A93-4C3A-812C-B5CF377E0E85 Q34632502-EA9B51A5-F0D2-4B6F-B547-027F1B8B1F4F Q34704085-15E5E926-6A77-4CC1-91E2-DA8659364EFD Q34769809-D86A1719-700F-4BA5-A57D-37E921BC451C Q34803868-915B6B61-7757-4596-AB58-0E59EF391D6A Q34971617-4A17FBE6-BD9F-433B-A33A-6F4DEAD58321 Q34974058-4DEDC9E9-3533-4A00-9690-77EC09756980 Q35051034-E35DD801-4FC8-4A4B-8C5B-3C63D9CDBA43 Q35124844-97925B7C-6EF7-49C5-8D68-A9F17130B0E9 Q35153656-7FA8CA9C-0B70-44F4-8A88-2E2CDAD30EA9 Q35210402-B3014648-1102-4CE2-AD0B-4B48C586B202

P2860

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.

http://www.wikidata.org/entity/Q34747331

description

1998 nî lūn-bûn

@nan

1998 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@ast

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@en

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@nl

type

label

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@ast

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@en

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@nl

prefLabel

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@ast

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@en

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@nl

P1433

Q34747331-799007D1-0A93-449B-86B5-4149B70BDFEB

P1476

Q34747331-895F4754-4086-4F5A-8840-64C909C0087F

P2093

Q34747331-07CB6359-5BE3-45D8-B8EC-3E323A97500F

Q34747331-4DE07C8E-3360-4318-861F-32810F68CA7C

Q34747331-52DE5DCA-B2FA-444F-A17B-7853295301A5

Q34747331-5338A5B0-E731-4414-85CE-171B8D07157F

Q34747331-8A40104A-B9D6-454D-99A5-B3A5309CD409

Q34747331-90279DFA-6DD1-4881-A9D0-2CA0C9A92721

Q34747331-904EA31E-FBDC-4096-AA33-C92FFA57E497

Q34747331-94BECC30-9B7C-43B9-BB33-4F37F270479F

Q34747331-A8BC963C-F0ED-40E7-8225-46FA9277D880

Q34747331-B0FC12C0-78F8-4C5C-9621-8D73B9A6EA9A

P304

Q34747331-D2AA1C52-4DB0-4892-BE5A-73953107AE4E

P31

Q34747331-978CE89D-6196-47BA-A986-980332E118B8

P356

Q34747331-97D29156-16E6-4E71-A47E-BF64E0F1D3D4

P407

Q34747331-4DB04ACD-CB66-43E2-A206-253027610503

P433

Q34747331-9F5ADAAB-A375-4E38-81D4-9BF6DD95E022

P478

Q34747331-DC22CDD8-679A-4444-B57B-2EF286F737AE

P577

Q34747331-C7A603AA-8694-4C2F-908C-CABF2DE92A4E

P698

Q34747331-6A7A4329-85E9-4ED3-999B-6FF40A82029D

P921

Q34747331-099F6ABC-9BCE-4D18-99C4-F126100B88C4

Q34747331-B34E02D1-EDB5-4036-B339-3AC790154A41

P356

NEJM199805213382104

P1433

The New England Journal of Medicine

P1476

Chlorambucil in indolent chron ...... Chronic Lymphocytic Leukemia.

@en

P2093

Binet JL

http://www.w3.org/2001/XMLSchema#string

Cazin B

http://www.w3.org/2001/XMLSchema#string

Desablens B

http://www.w3.org/2001/XMLSchema#string

Dighiero G

http://www.w3.org/2001/XMLSchema#string

Dreyfus B

http://www.w3.org/2001/XMLSchema#string

Jaubert J

http://www.w3.org/2001/XMLSchema#string

Leblay R

http://www.w3.org/2001/XMLSchema#string

Lepeu G

http://www.w3.org/2001/XMLSchema#string

Leporrier M

http://www.w3.org/2001/XMLSchema#string

Maloum K

http://www.w3.org/2001/XMLSchema#string

P304

1506-1514

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199805213382104

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P577

1998-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9593789

http://www.w3.org/2001/XMLSchema#string

P921